What is Phreesia's market cap?

Phreesia (PHR) has a market capitalization of $668.8M and trades on NYSE.

What is Phreesia's revenue and profitability?

Phreesia generated $495.6M in trailing twelve-month revenue with net income of $9.2M, representing a net margin of 1.9%. Gross margin stands at 85.4%, with free cash flow of $76.0M. These figures are based on the Q2 2026 filing.

Who are Phreesia's competitors?

Phreesia's key competitors include Veeva Systems, InfuSystem Holdings, Inc., Claritev Corporation, and others. These companies compete in similar markets and product categories.

Who does Phreesia partner with?

Phreesia's notable partners include Epic Systems, Oracle Health.

What subsidiaries does Phreesia have?

Phreesia's subsidiaries include AccessOne Parent Holdings, Inc., Insignia Health, MediFind.

Where is Phreesia headquartered?

Phreesia is headquartered in United States of America and employs approximately 1,438 people. It has been publicly traded since 2019.

Phreesia

PHR

Phreesia provides a comprehensive software, payments, and engagement platform designed to streamline healthcare delivery by managing patient access, affordability, and health outcomes.

Market cap

$668.8M-60.8%

Revenue$495.6M+14.1%

Net income$9.2M+122%

Free cash flow$76.0M+108%

EPS (diluted)$0.15+120%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2027 report

May 27, 2026

Revenue$130.9MBeat by $856.7K EPS$0.05Beat by $0.03

Read the full report

Next report

Sep 3, 2026 (in 2 months)

Revenue estimate$129.2M

EPS estimate$0.11

Financials

Q1 2027

Income statement

See full

Revenue$130.9M+12.9%

Gross profit$113.3M+14.1%

Operating income$6.7M+305%

Net income$3.0M+176%

EPS (diluted)$0.05+171%

Balance sheet

See full

Total debt$98.3M+242%

Total equity$359.1M+27.3%

Total assets$666.1M+66.4%

Cash flow

See full

Operating cash flow$23.9M+61.1%

CapEx$4.3M+23.0%

Free cash flow$19.6M+72.9%

Valuation & ratios

Valuation

See full

Market cap$668.8M-60.8%

P/E72.8×—

P/S1.4×-2.5×

Profitability

See full

Gross margin85.4%+0.8pp

Operating margin0.7%+0.4pp

Net margin1.9%+1.0pp

FCF margin15.3%+6.9pp

Returns & leverage

See full

Return on equity2.9%+1.5pp

Debt / equity0.3×+0.2×

Current ratio1.8×-0.2×

Segments

By product

See full

Subscription and related services$52.7M-3.0%

Payment solutions$41.9M—

Network solutions$36.3M+14.6%

By segment

See full

Technology Solutions Segment$130.9M+12.9%

Competitors

By market cap

Veeva Systems$30.8B-32.9%

BrightSpring Health Services, Inc.$14.0B+263%

ExlService Holdings$4.2B-42.6%

Phreesia$668.8M-60.4%

Claritev Corporation$560.9M-29.4%

Paysign$490.9M+9.6%

InfuSystem Holdings$196.6M+49.9%

Sensus Healthcare$48.1M-36.3%

By revenue growth

Paysign+43.4%

BrightSpring Health Services, Inc.+28.0%

Veeva Systems+16.3%

Phreesia+14.1%

ExlService Holdings+13.4%

Claritev Corporation+5.5%

InfuSystem Holdings+3.5%

By net margin

Veeva Systems28.37%+1.0pp

ExlService Holdings11.66%+0.3pp

Paysign11.37%+1.8pp

InfuSystem Holdings5.56%+3.2pp

BrightSpring Health Services, Inc.2.27%+2.3pp

Phreesia1.85%+11.7pp

Claritev Corporation-29.27%+97.7pp

Profile

Phreesia provides a comprehensive software, payments, and engagement platform designed to streamline healthcare delivery by managing patient access, affordability, and health outcomes. The company's cloud-based architecture integrates with existing provider workflows to automate administrative tasks, facilitate digital intake, and optimize financial performance for healthcare organizations.

Competitive position

Phreesia is a leading provider of patient intake and engagement solutions, facilitating approximately one in six ambulatory patient visits in the United States.

GeographiesUnited States

Customer segmentsHealthcare Providers, Life Sciences Companies, Government Agencies

Business modelSubscription SaaS, Transaction-based, Advertising and Engagement

SuppliersCloud infrastructure providers, Electronic Medical Record (EMR) systems, Practice Management Systems, Payment card networks

CustomersAmbulatory care centers, Large health systems, Pharmaceutical companies, Medical device manufacturers

CountryUnited States of America

Listed2019

Employees1.4K

CEOChaim Indig

SectorHealthcare

IndustryMedical - Healthcare Information Services

Websitephreesia.com

FilingsSEC EDGAR

Ask your AI about Phreesia.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phreesia's market cap?: Phreesia (PHR) has a market capitalization of $668.8M and trades on NYSE.
What is Phreesia's revenue and profitability?: Phreesia generated $495.6M in trailing twelve-month revenue with net income of $9.2M, representing a net margin of 1.9%. Gross margin stands at 85.4%, with free cash flow of $76.0M. These figures are based on the Q2 2026 filing.
Who are Phreesia's competitors?: Phreesia's key competitors include Veeva Systems, InfuSystem Holdings, Inc., Claritev Corporation, and others. These companies compete in similar markets and product categories.
Who does Phreesia partner with?: Phreesia's notable partners include Epic Systems, Oracle Health.
What subsidiaries does Phreesia have?: Phreesia's subsidiaries include AccessOne Parent Holdings, Inc., Insignia Health, MediFind.
Where is Phreesia headquartered?: Phreesia is headquartered in United States of America and employs approximately 1,438 people. It has been publicly traded since 2019.